These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 28109780)

  • 21. Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment.
    Asth L; Iglesias LP; De Oliveira AC; Moraes MFD; Moreira FA
    Epilepsy Behav; 2021 Aug; 121(Pt B):106832. PubMed ID: 31839498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marijuana Use in Epilepsy: The Myth and the Reality.
    Detyniecki K; Hirsch L
    Curr Neurol Neurosci Rep; 2015 Oct; 15(10):65. PubMed ID: 26299273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity.
    Wall MB; Pope R; Freeman TP; Kowalczyk OS; Demetriou L; Mokrysz C; Hindocha C; Lawn W; Bloomfield MA; Freeman AM; Feilding A; Nutt D; Curran HV
    J Psychopharmacol; 2019 Jul; 33(7):822-830. PubMed ID: 31013455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.
    Reddy DS
    Clin Pharmacol Ther; 2017 Feb; 101(2):182-184. PubMed ID: 27506704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
    Legare CA; Raup-Konsavage WM; Vrana KE
    Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoting cannabis products to pharmaceutical drugs.
    Koltai H; Poulin P; Namdar D
    Eur J Pharm Sci; 2019 Apr; 132():118-120. PubMed ID: 30851400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cannabinoids on resting state functional brain connectivity: A systematic review.
    Lorenzetti V; Gaillard A; Thomson D; Englund A; Freeman TP
    Neurosci Biobehav Rev; 2023 Feb; 145():105014. PubMed ID: 36563921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
    Deiana S
    Drug Test Anal; 2013 Jan; 5(1):46-51. PubMed ID: 23109356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Pharmacological Basis of Cannabis Therapy for Epilepsy.
    Reddy DS; Golub VM
    J Pharmacol Exp Ther; 2016 Apr; 357(1):45-55. PubMed ID: 26787773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.
    Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical considerations in medical cannabis administration and dosing.
    MacCallum CA; Russo EB
    Eur J Intern Med; 2018 Mar; 49():12-19. PubMed ID: 29307505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoids: for better and for worse
.
    Thibaut F; Hoehe MR
    Dialogues Clin Neurosci; 2020 Sep; 22(3):201-204. PubMed ID: 33162763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis's chemical synergies.
    Worth T
    Nature; 2019 Aug; 572(7771):S12-S13. PubMed ID: 31462791
    [No Abstract]   [Full Text] [Related]  

  • 34. Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis.
    Pérez-Acevedo AP; Pacifici R; Mannocchi G; Gottardi M; Poyatos L; Papaseit E; Pérez-Mañá C; Martin S; Busardò FP; Pichini S; Farré M
    Phytother Res; 2021 Mar; 35(3):1646-1657. PubMed ID: 33155722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish.
    Thornton C; Dickson KE; Carty DR; Ashpole NM; Willett KL
    Epilepsy Behav; 2020 Sep; 110():107152. PubMed ID: 32585475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Should ophtalmologists recommend medical cannabis to patients with glaucoma?].
    Mouhammad ZA; Kolko M
    Ugeskr Laeger; 2018 Jul; 180(29):. PubMed ID: 30020072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.
    Todd SM; Arnold JC
    Br J Pharmacol; 2016 Jan; 173(1):53-65. PubMed ID: 26377899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
    Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
    Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrative Medicine: Cannabis and Cannabis-Related Drugs.
    Moss DA; Hawks MK; Snyder MJ; Crawford PF
    FP Essent; 2021 Jun; 505():28-34. PubMed ID: 34128629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.